| 1 |
Duan QY, Zhu YX, Jia HR, Guo Y, Zhang X, Gu R, Li C, Wu FG. Platinum-Coordinated Dual-Responsive Nanogels for Universal Drug Delivery and Combination Cancer Therapy. Small 2022;18:e2203260. [PMID: 36333101 DOI: 10.1002/smll.202203260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Pourmadadi M, Eshaghi MM, Rahmani E, Ajalli N, Bakhshi S, Mirkhaef H, Lasemi MV, Rahdar A, Behzadmehr R, Díez-pascual AM. Cisplatin-loaded nanoformulations for cancer therapy: A comprehensive review. Journal of Drug Delivery Science and Technology 2022;77:103928. [DOI: 10.1016/j.jddst.2022.103928] [Reference Citation Analysis]
|
| 3 |
Yu B, Deng Y, Jia F, Wang Y, Jin Q, Ji J. A Supramolecular Nitric Oxide Nanodelivery System for Prevention of Tumor Metastasis by Inhibiting Platelet Activation and Aggregation. ACS Appl Mater Interfaces 2022. [DOI: 10.1021/acsami.2c15882] [Reference Citation Analysis]
|
| 4 |
Zhong L, Xia Y, He T, Wenjie S, Jinxia A, Lijun Y, Hui G. Polymeric photothermal nanoplatform with the inhibition of aquaporin 3 for anti-metastasis therapy of breast cancer. Acta Biomater 2022:S1742-7061(22)00589-X. [PMID: 36115652 DOI: 10.1016/j.actbio.2022.09.026] [Reference Citation Analysis]
|
| 5 |
Yang Y, Sun J, Peng F, Liu H, Zhao G, Chen J, Zhang W, Qiu F. Enhanced Antitumor Activity of Lidocaine Nanoparticles Encapsulated by a Self-Assembling Peptide. Front Pharmacol 2022;13:770892. [DOI: 10.3389/fphar.2022.770892] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Zhang X, Wei P, Wang Z, Zhao Y, Xiao W, Bian Y, Liang D, Lin Q, Song W, Jiang W, Wang H. Herceptin-Conjugated DOX-Fe3O4/P(NIPAM-AA-MAPEG) Nanogel System for HER2-Targeted Breast Cancer Treatment and Magnetic Resonance Imaging. ACS Appl Mater Interfaces 2022;14:15956-69. [PMID: 35378977 DOI: 10.1021/acsami.1c24770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Moorthy A, Eochagáin AN, Buggy DJ. Can Acute Postoperative Pain Management After Tumour Resection Surgery Modulate Risk of Later Recurrence or Metastasis? Front Oncol 2021;11:802592. [PMID: 34976840 DOI: 10.3389/fonc.2021.802592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Roy A, Guha Ray P, Manna K, Banerjee C, Dhara S, Pal S. Poly(N-vinyl imidazole) Cross-Linked β-Cyclodextrin Hydrogel for Rapid Hemostasis in Severe Renal Arterial Hemorrhagic Model. Biomacromolecules 2021. [PMID: 34755513 DOI: 10.1021/acs.biomac.1c01174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Anooj E, Charumathy M, Sharma V, Vibala B, Gopukumar S, Jainab SB, Vallinayagam S. Nanogels: An overview of properties, biomedical applications, future research trends and developments. Journal of Molecular Structure 2021;1239:130446. [DOI: 10.1016/j.molstruc.2021.130446] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 10 |
Chen R, Ni S, Chen W, Liu M, Feng J, Hu K. Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles. Int J Nanomedicine 2021;16:5265-79. [PMID: 34376979 DOI: 10.2147/IJN.S313166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Agnello L, Tortorella S, d'Argenio A, Carbone C, Camorani S, Locatelli E, Auletta L, Sorrentino D, Fedele M, Zannetti A, Franchini MC, Cerchia L. Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors. J Exp Clin Cancer Res 2021;40:239. [PMID: 34294133 DOI: 10.1186/s13046-021-02039-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 12 |
Sun D, Li YC, Zhang XY. Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer. Front Pharmacol 2021;12:681223. [PMID: 34122108 DOI: 10.3389/fphar.2021.681223] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 13 |
Bagheri F, Darakhshan S, Mazloomi S, Shiri Varnamkhasti B, Tahvilian R. Dual loading of Nigella sativa oil-atorvastatin in chitosan-carboxymethyl cellulose nanogel as a transdermal delivery system. Drug Dev Ind Pharm 2021;47:569-78. [PMID: 33819116 DOI: 10.1080/03639045.2021.1892742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
González-urías A, Manzanares-guevara LA, Licea-claveríe Á, Ochoa-terán A, Licea-navarro AF, Bernaldez-sarabia J, Zapata-gonzález I. Stimuli responsive nanogels with intrinsic fluorescence: Promising nanovehicles for controlled drug delivery and cell internalization detection in diverse cancer cell lines. European Polymer Journal 2021;144:110200. [DOI: 10.1016/j.eurpolymj.2020.110200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 15 |
Yang Q, Xiao Y, Liu Q, Xu X, Peng J. Carrier-Free Small-Molecule Drug Nanoassembly Elicits Chemoimmunotherapy via Co-inhibition of PD-L1/mTOR. ACS Appl Bio Mater 2020;3:4543-55. [PMID: 35025453 DOI: 10.1021/acsabm.0c00470] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 16 |
Zhou D, Wang L, Cui Q, Iftikhar R, Xia Y, Xu P. Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia. Front Cell Dev Biol 2020;8:565. [PMID: 32766241 DOI: 10.3389/fcell.2020.00565] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 17 |
Yang F, Zhao Z, Sun B, Chen Q, Sun J, He Z, Luo C. Nanotherapeutics for Antimetastatic Treatment. Trends Cancer 2020;6:645-59. [PMID: 32448754 DOI: 10.1016/j.trecan.2020.05.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 18 |
Wei P, Czaplewska JA, Wang L, Schubert S, Brendel JC, Schubert US. Straightforward Access to Glycosylated, Acid Sensitive Nanogels by Host-Guest Interactions with Sugar-Modified Pillar[5]arenes. ACS Macro Lett 2020;9:540-5. [PMID: 35648509 DOI: 10.1021/acsmacrolett.0c00030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 19 |
Roy A, Samanta S, Singha K, Maity P, Kumari N, Ghosh A, Dhara S, Pal S. Development of a Thermoresponsive Polymeric Composite Film Using Cross-Linked β-Cyclodextrin Embedded with Carbon Quantum Dots as a Transdermal Drug Carrier. ACS Appl Bio Mater 2020;3:3285-93. [DOI: 10.1021/acsabm.0c00246] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Yin Y, Hu B, Yuan X, Cai L, Gao H, Yang Q. Nanogel: A Versatile Nano-Delivery System for Biomedical Applications. Pharmaceutics 2020;12:E290. [PMID: 32210184 DOI: 10.3390/pharmaceutics12030290] [Cited by in Crossref: 63] [Cited by in F6Publishing: 70] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 21 |
Farooq MA, Aquib M, Farooq A, Haleem Khan D, Joelle Maviah MB, Sied Filli M, Kesse S, Boakye-Yiadom KO, Mavlyanova R, Parveen A, Wang B. Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview. Artif Cells Nanomed Biotechnol 2019;47:1674-92. [PMID: 31066300 DOI: 10.1080/21691401.2019.1604535] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 22 |
Yang Q, Xiao Y, Yin Y, Li G, Peng J. Erythrocyte Membrane-Camouflaged IR780 and DTX Coloading Polymeric Nanoparticles for Imaging-Guided Cancer Photo-Chemo Combination Therapy. Mol Pharm 2019;16:3208-20. [PMID: 31145853 DOI: 10.1021/acs.molpharmaceut.9b00413] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 23 |
Xia W, Wang L, Yu D, Mu X, Zhou X. Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis. Mol Med Rep 2019;20:1333-42. [PMID: 31173241 DOI: 10.3892/mmr.2019.10363] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Feng Y, Li N, Yin H, Chen T, Yang Q, Wu M. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs. Mol Pharmaceutics 2019;16:422-36. [DOI: 10.1021/acs.molpharmaceut.8b01073] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 8.4] [Reference Citation Analysis]
|
